May 22, 2025, 01:00 AM by User Not Found

Bio-IT World | Singapore researchers have developed an innovative artificial intelligence platform that creates personalized “digital twins” of patients to optimize drug dosing on an individual basis. The CURATE.AI platform, developed by Dr. Dean Ho and his team at the National University of Singapore's Institute for Digital Medicine (WisDM), represents a significant advancement in precision medicine by dynamically adjusting treatment regimens based on real-time patient responses.

May 21, 2025, 08:57 AM by

4D Path, a company dedicated to personalizing cancer care through its unprecedented approach to predicting tumor response, recently convened its Scientific Advisory Board (SAB), bringing together an exceptional group of oncology, pathology, and translational research leaders, each deeply committed to advancing precision oncology and translating innovation into patient impact.

May 21, 2025, 08:57 AM by

Growth in dedicated sample stability facilities at Tramore (Ireland) site to meet demand for flexible, regulatory-compliant storage solutions

May 21, 2025, 01:00 AM by User Not Found

Bio-IT World | Genmab partnered with Genedata to address the challenges of capturing chromatography data. Their effort earned them a 2025 Innovative Practices Awards for their joint development of Chromatics, a new Genedata product developed to meet the needs of chromatography data. In their pursuit of differentiated therapeutic antibodies, Genmab found chromatography data a particularly unwieldy piece of the pipeline.

May 20, 2025, 08:41 AM by

May 20, 2025, 01:00 AM by User Not Found

Bio-IT World | DNA testing company 23andMe was purchased by Regeneron for $256 million. The deal is expected to close on July 1. The deal includes “substantially all assets” of 23and Me, but it will not include Lemonaid Health, a telehealth services provider that 23andMe plans to gradually close.

May 16, 2025, 08:36 AM by

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced financial results for the first quarter ended March 31, 2025, and provided a corporate strategic update.

May 16, 2025, 08:36 AM by

May 16, 2025, 08:36 AM by

My name is Nora Beik, and I am reaching out from Zymo Research to share our latest press release announcing the upcoming BioFestival at Johns Hopkins University, a campus event dedicated to accelerating innovation, celebrating sustainability, and supporting early-career researchers. BioFestival is a growing initiative led by Zymo Research in partnership with top-tier academic institutions, with the goal of empowering the next generation of scientists. This latest installment—hosted in collaboration with Johns Hopkins University—highlights Zymo Research’s ongoing commitment to serving as a trusted partner to academia and a leader in sample preparation for life sciences. We invite you to read the full press release here: https://www.zymoresearch.com/blogs/press-releases/biofestival-johns-hopkins-university We would greatly appreciate it if you would consider sharing this news with your readers. If you require any additional information, high-resolution images, or would like to arrange an interview with one of our experts, please do not hesitate to reach out. I look forward to the opportunity to collaborate with your team. Thank you for your time and consideration.

May 16, 2025, 08:36 AM by

Lannan and new Board of Directors member Jason Blessing will help propel the company’s next phase of growth

May 15, 2025, 08:42 AM by

This major study milestone highlights START’s commitment to bringing novel cancer therapies to patients through community-based early-phase clinical trials.

May 15, 2025, 08:42 AM by

May 15, 2025, 08:42 AM by

CapeStart announced a major new release of MadeAi™, its GenAI-based platform whose enhancements also power the MadeAi-LR solution for systematic literature review (SLR). MadeAi helps time-strapped teams to advance the pace of scientific research by cutting literature review time in half and delivering 90% accuracy.

May 15, 2025, 01:00 AM by User Not Found

Bio-IT World | Ari Berman, CEO of Bio Team, opened the Trends from the Trenches session at the Bio-IT World Conference & Expo by following the data journey from generation to application and outlining the pain points along the way. At the end of his presentation, he got political, challenging the audience to stay engaged in science and the scientific community no matter the political winds.

May 14, 2025, 01:00 AM by User Not Found

Bio-IT World | Sweden is positioning itself at the forefront of precision medicine with an ambitious new initiative that aims to transform how scientific research translates to patient care. The Precision Omics Initiative Sweden (PROMISE), recently outlined in Nature Medicine, seeks to revolutionize healthcare by creating a seamless flow of data between research laboratories and clinical settings.

May 13, 2025, 09:26 AM by User Not Found

Bio-IT World | Last month, a cohort of 40 participants convened for the Common Fund Data Ecosystem Open Source and FAIR Data Hackathon at the 6th Annual Bio-IT World Hackathon held April 1–2, 2025 in Boston, Mass. Teams tackled a broad range of challenges including linking glycoenzyme expression to disease pathways, enabling cellular-level comparisons using HuBMAP imaging data, and more.

May 13, 2025, 09:25 AM by

May 13, 2025, 09:25 AM by

Watson-Marlow Fluid Technology Solutions (WMFTS) will showcase its peristaltic pumps and fluid path technologies for the pharmaceutical industry during PHARMINTECH at the Fiera Milano, Italy (27-30 May, 2025).

May 12, 2025, 08:41 AM by

• Prof Heather Pinkett and Dr Dafydd Owen to lead ELRIG’s flagship event • Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate “A Festival of Life Science” • Event supported by VisitBritain showcases UK life science sector and extends international reach

May 9, 2025, 08:41 AM by